A9564 HCPCS Level II code: Chromic phosphate p-32 suspension, therapeutic, per millicurie
A9564 is the HCPCS code for “Chromic phosphate p-32 suspension, therapeutic, per millicurie” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
A9564Chromic phosphate p-32 suspension, therapeutic, per millicurie
Short description: P32 chromic phosphate
HCPCS · United States
Medicare details
The indicators CMS publishes with A9564 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Other carrier priced
- Type of service
- Therapeutic radiology
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Jan 1, 2006
Where A9564 sits
- 1A codesAmbulance, supplies and miscellaneous
- 2Active code A9564Chromic phosphate p-32 suspension, therapeutic, per millicurie
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code A9564 mean?
A9564 is the HCPCS code for “Chromic phosphate p-32 suspension, therapeutic, per millicurie” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover A9564?
CMS lists A9564’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside A9564
All A codesA9558Xenon xe-133 gas, diagnostic, per 10 millicuriesA9559Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurieA9560Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuriesA9561Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuriesA9562Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuriesA9563Sodium phosphate p-32, therapeutic, per millicurieA9566Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuriesA9567Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuriesA9568Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuriesA9569Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study doseA9570Indium in-111 labeled autologous white blood cells, diagnostic, per study doseA9571Indium in-111 labeled autologous platelets, diagnostic, per study dose